NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Kristi Noem’s $220 million DHS ads outspent blockbusters like “Barbie” and “Sinners,” raising questions about the department’s use of taxpayer dollars.Read More